852 related articles for article (PubMed ID: 34729690)
1. Neuropathology of Alzheimer's Disease.
Trejo-Lopez JA; Yachnis AT; Prokop S
Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
[TBL] [Abstract][Full Text] [Related]
2. Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure.
Tsering W; Hery GP; Phillips JL; Lolo K; Bathe T; Villareal JA; Ruan IY; Prokop S
Acta Neuropathol Commun; 2023 Dec; 11(1):190. PubMed ID: 38037144
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
5. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
Cong C; Zhang W; Qian X; Qiu W; Ma C
J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
[TBL] [Abstract][Full Text] [Related]
6. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
7. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
Jellinger KA
J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
[TBL] [Abstract][Full Text] [Related]
8. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
[TBL] [Abstract][Full Text] [Related]
9. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
10. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
11. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
[TBL] [Abstract][Full Text] [Related]
12. Early Alzheimer-type lesions in cognitively normal subjects.
Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases.
Kurihara M; Matsubara T; Morimoto S; Arakawa A; Ohse K; Kanemaru K; Iwata A; Murayama S; Saito Y
Acta Neuropathol Commun; 2024 Mar; 12(1):48. PubMed ID: 38539238
[TBL] [Abstract][Full Text] [Related]
14. Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement.
Musiek ES; Holtzman DM
Curr Opin Neurol; 2012 Dec; 25(6):715-20. PubMed ID: 23041958
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
16. Neuropathological changes in aging brain.
Xekardaki A; Kövari E; Gold G; Papadimitropoulou A; Giacobini E; Herrmann F; Giannakopoulos P; Bouras C
Adv Exp Med Biol; 2015; 821():11-7. PubMed ID: 25416106
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
[TBL] [Abstract][Full Text] [Related]
19. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
[TBL] [Abstract][Full Text] [Related]
20. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]